Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. - Wikidata - awgldk - TriplyDB

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

http://www.wikidata.org/entity/Q36575274

about

Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein An Epstein-Barr virus protein interacts with Notch BS69, a specific adaptor in the latent membrane protein 1-mediated c-Jun N-terminal kinase pathway The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein Identification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagen Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB The oncogenic protein kinase Tpl-2/Cot contributes to Epstein-Barr virus-encoded latent infection membrane protein 1-induced NF-kappaB signaling downstream of TRAF2 Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5 Epstein-Barr virus immortalization: Notch2 interacts with CBF1 and blocks differentiation EBNA2 and activated Notch induce expression of BATF The viral etiology of AIDS-associated malignancies Epstein-Barr virus provides a new paradigm: a requirement for the immediate inhibition of apoptosis.Microvesicles and viral infection Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease Structural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIH Epstein-Barr virus latent genes Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1 Early events associated with infection of Epstein-Barr virus infection of primary B-cells Epstein-Barr virus nuclear antigen 1 does not cause lymphoma in C57BL/6J mice Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation Exosomes derived from Burkitt's lymphoma cell lines induce proliferation, differentiation, and class-switch recombination in B cells.EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas.Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP.Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes The potential of gene transfer into primary B-CLL cells using recombinant virus vectors.Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents.Immune enhancement of skin carcinogenesis by CD4+ T cells.Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency.Epstein-Barr virus involvement in T-cell malignancy: significance in adult T-cell leukemia.Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection Difference in cytokine production and cell cycle progression induced by Epstein-Barr virus Lmp1 deletion variants in Kmh2, a Hodgkin lymphoma cell line.

P2860

Q24311421-D4F43443-9137-45A9-A107-D2011F52B3E3 Q24529019-C18BD391-8BB6-4F2F-B01B-0002BAA41FBA Q24537608-FA489952-9124-4F84-B54C-AB3ED4CE9AA2 Q24554457-F6CC10BC-F114-4DAD-9398-8F85F2CB5931 Q24556627-99555860-4FEA-45F7-9331-36EEF8EDF339 Q24562912-8486F49B-1F97-43B9-96D1-F005EAB9FCC8 Q24564927-81756A39-B365-4C53-B6D3-0A0412A2B1F6 Q24599252-4B363F5B-24B8-40D0-B93B-0406CD984419 Q24633907-C6D03209-0346-41BB-8798-1EFBC5A6C7F8 Q24646670-042EB3C3-CBF1-432F-8FA7-C040D1DE52B4 Q24646694-ADB657DE-2A96-47F7-AE53-BC8A73B52FFE Q24674848-887F9B22-CF70-4537-BCB8-D915DCAF1047 Q24675583-A7D341DB-03EE-4909-9ACE-64E5CC2E78E3 Q24678677-E6AFD9D0-7882-47D8-90C7-CA559C92D7C6 Q24679432-43B71E6A-B402-46FF-89CB-85C7114031EA Q24685892-539E9DF9-88E9-41DF-BA7A-1888E57AAED1 Q24816875-AB8A9874-1425-4D2D-AB6B-490F98AF5649 Q26823408-55BC00FD-6F0C-458A-8373-DE3630D1E7D1 Q26859114-16A58A53-FC6B-4ECD-A2FF-61A9DC27D9C1 Q26998401-A46F642B-74F2-4C52-B92B-E5553BCB7ECA Q27682610-D60288EE-DCC2-4F26-B6AF-41B62D8C228A Q28082701-C6EF489E-0092-48BD-A0C3-594397A01D01 Q28114910-B84AE919-82A2-47AD-9165-735F559335BA Q28117643-70B8E549-E6A3-459C-98FC-08AB0830BA96 Q28361340-5CDE888D-E2C8-4773-B79B-2BAA9EE2D08C Q28476230-48E5BE53-0787-4D6B-9B48-C01C68841544 Q28594944-084F3082-BF6C-4BC1-A393-5BFC48AD5F6A Q28731826-83A0DB14-0156-4ABD-BF65-4EAE68BD38B5 Q30587658-D8B041AE-0B89-45CE-AF3E-4378BC663F8C Q30837949-08F51D6C-B9FA-44CA-B1BA-97AC64BB82D9 Q30939262-5D8F0CD3-722A-4752-B986-8D7C2CEAF13E Q30979226-1A4FFA24-3552-4877-832B-2518EFCA48E8 Q31104353-116C7D1D-ADCF-4787-BFFF-C068943B7D1F Q31811732-82F8C8F6-4655-41C4-B75B-1B9ADCF0FFD6 Q33186709-EFE10429-BDFE-4EC5-8B5D-3EAF54D517C4 Q33270518-BF98C45E-ECA6-49EE-A752-CABE621A846B Q33643988-50CE7756-0AA9-4772-BFED-AAF5DFDE4FBB Q33643991-D1C4B2CF-88C6-4E30-AFB1-CA14AC76746B Q33658144-7002BC53-7A0A-4764-AC23-6579CCA80ED3 Q33673610-10CD6005-0391-41A7-8D64-C09F120AA3DE

P2860

Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.

http://www.wikidata.org/entity/Q36575274

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Epstein-Barr virus latent memb ...... phocyte growth transformation.

@ast

Epstein-Barr virus latent memb ...... phocyte growth transformation.

@en

type

label

Epstein-Barr virus latent memb ...... phocyte growth transformation.

@ast

Epstein-Barr virus latent memb ...... phocyte growth transformation.

@en

prefLabel

Epstein-Barr virus latent memb ...... phocyte growth transformation.

@ast

Epstein-Barr virus latent memb ...... phocyte growth transformation.

@en

P1433

Q36575274-6398029B-0052-45D3-B51D-E9579177BEB9

P1476

Q36575274-CB63437A-939A-497D-AE9F-EAA11A02D730

P2093

Q36575274-EB3FE99A-C87F-44AE-950E-C68D71D7EE5D

Q36575274-ECB78C45-1C02-4BDA-90B9-79E1FEE96714

P2860

Q36575274-0765C630-D98B-4212-A358-D6606F848395

Q36575274-103AA906-4340-4172-B744-CD965D8E12E5

Q36575274-1A577C15-B702-4F92-BB12-6438083A1588

Q36575274-2FEF530C-FDD5-43B3-802E-783AA8705132

Q36575274-3F5C4561-B483-48A1-BB6E-12306C1989CB

Q36575274-4550B057-11D9-4AFB-9E02-B80CEF97DD51

Q36575274-4D870BE3-0AB0-46D3-994D-F842DB42C71E

Q36575274-51136834-A029-4B88-85D5-F97C1D5143B1

Q36575274-546A494E-36D2-4412-A151-093E88B647EC

Q36575274-58CD03AA-5573-4F4B-B7E5-2B6628285CA2

P304

Q36575274-D771D5EA-C92B-4C3A-BAB1-1A3AB92A2C36

P31

Q36575274-3367AC5B-F92A-4B22-A322-434E95F063F2

P356

Q36575274-7CA01332-D180-4818-8335-20068CD98A7D

P407

Q36575274-05CD5371-6D15-4F6C-9356-881317BDA399

P433

Q36575274-12D48049-4ECF-45DF-B46E-C10E687F89A2

P478

Q36575274-17B3902A-3D6F-455D-8BB1-EBDF9AFCC215

P50

Q36575274-DD4595D0-9E53-492A-B231-626253244727

P577

Q36575274-A372CAAC-1EEC-42B3-BA0A-772AF6B6945E

P5875

Q36575274-AEB3495C-C987-4294-935B-1E09BA918416

P698

Q36575274-6C0E22A4-337B-40FB-9411-8BBC73657EDF

P921

Q36575274-26A31396-9CD2-4E19-A357-0F750BC048C2

P932

Q36575274-69C64F42-746E-4157-9DBC-EA4F89D88AEA

P356

PNAS.90.19.9150

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Epstein-Barr virus latent memb ...... phocyte growth transformation.

@en

P2093

K M Izumi

http://www.w3.org/2001/XMLSchema#string

K M Kaye

http://www.w3.org/2001/XMLSchema#string

P2860

Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation

The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential.

The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro.

Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.

Second-site homologous recombination in Epstein-Barr virus: insertion of type 1 EBNA 3 genes in place of type 2 has no effect on in vitro infection.

Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro

Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells

Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

P304

9150-9154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.90.19.9150

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

Elliott D. Kieff

P577

1993-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14782979

http://www.w3.org/2001/XMLSchema#string

P698

8415670

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

47519

http://www.w3.org/2001/XMLSchema#string